Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Sponsor: Johns Hopkins University
Summary
The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will result in faster and more substantial recovery of motor and sensory function following surgical repair of injured peripheral nerves. Patients with upper extremity nerve injuries will be randomly assigned to receive either tesamorelin treatment or no treatment. Assessments for nerve regeneration, muscle function, and sensation will be conducted every three months for a total of 12 months. Outcomes in patients receiving tesamorelin will be compared to those in the untreated group to determine the effectiveness of tesamorelin as a therapeutic intervention for nerve injuries.
Official title: Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy, and Improve Functional Outcomes Following Peripheral Nerve Injury
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2018-06-01
Completion Date
2027-12
Last Updated
2025-11-12
Healthy Volunteers
No
Conditions
Interventions
Tesamorelin 2 Milligrams (MG)
Daily self-administered study drug
Locations (1)
Sami Tuffaha
Baltimore, Maryland, United States